Mu opioid receptor agonist DAMGO produces place conditioning, abstinence-induced withdrawal, and naltrexone-dependent locomotor activation in planarians

Por Dziedowiec, Emily, Nayak, Sunil U., Gruver, Keenan S., Jennings, Tyra, Tallarida, Christopher S., Rawls, Scott M.
Publicado no Neuroscience (2018)

Chemokines and ‘bath salts’: CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats

Por Oliver, Chicora F., Simmons, Steven J., Nayak, Sunil U., Smith, Garry R., Reitz, Allen B., Rawls, Scott M.
Publicado no Drug Alcohol Depend (2018)

Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator

Por Gregg, Ryan A., Hicks, Callum, Nayak, Sunil U., Tallarida, Christopher S., Nucero, Paul, Reitz, Allen B., Smith, Garry R., Rawls, Scott M.
Publicado no Neuropharmacology (2016)

Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG)

Por Hicks, Callum, Gregg, Ryan A., Nayak, Sunil U., Cannella, Lee Anne, Schena, Giana J., Tallarida, Christopher S., Reitz, Allen B., Smith, Garry R., Rawls, Scott M.
Publicado no Psychopharmacology (Berl) (2017)

Dopamine D1-like receptor agonist and D2-like receptor antagonist (−)-Stepholidine reduces reinstatement of drug-seeking behavior for 3,4-methylenedioxypyrovalerone (MDPV) in rats...

Por Hicks, Callum, Huang, Peng, Ramos, Linnet, Nayak, Sunil U., Caro, Yohanka, Reitz, Allen B., Smith, Garry R., Lee, David Y.W., Rawls, Scott M., Liu-Chen, Lee-Yuan
Publicado no ACS Chem Neurosci (2018)